Skip to main content
Clinical Trials/NCT00842010
NCT00842010CompletedNot Applicable

Hyperglycemic Non Diabetic (HND) Hospital Patients: Are They Different From Diabetic Hyperglycemic and Non-Hyperglycemic Non-Diabetic(NHND) Patients?

Cook County Health1 site in 1 country600 target enrollmentStarted: March 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
600
Locations
1
Primary Endpoint
Inpatient Mortality

Study Overview

Brief Summary

Retrospective nested non-matched case control study comparing patients by glycemic status

Detailed Description

This retrospective nested non-matched case control study compared patients directly admitted to the General Medicine Wards, not transferred from ICU with

  • hyperglycemia on admission but no previous diagnosis of diabetes
  • diabetic hyperglycemic patients
  • non hyperglycemic non diabetic patients from the same nested population.

The investigators' hypothesis is that the clinical characteristics and endpoints of the non diabetic hyperglycemics should be similar to the diabetic population and different from the non diabetic non hyperglycemic population.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Admitted to John H. Stroger Jr. Hospital
  • •Admitted to Internal Medicine Service from March-April 2006 and in October 2007

Exclusion Criteria

  • •Transfer from any intensive care unit (medical or surgical)

Outcomes

Primary Outcomes

Inpatient Mortality

Time Frame: From day 1 of admission until day of discharge

Mortality measured in number of events

Length of stay

Time Frame: Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge

Hospital stay measured in days

Secondary Outcomes

  • Frequency of SIRS on admission(Measures obtained 24 hours after patient is discharged. Clinical data obtained on day 1 of admission)
  • Rate of use of intravenous glucose drip(From day 1 of admission until day of discharge)
  • Frequency of inpatient infection(From day 1 of admission until day of discharge)
  • Frequency of steroid use(From day 1 of admission until day of discharge)

Investigators

Sponsor
Cook County Health
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Yannis Guerra

MD

Cook County Health

Study Sites (1)

Loading locations...

Similar Trials